NCT06530264 is a NA clinical trial of DCR in Acquired Nasolacrimal Duct Obstruction, sponsored by Minia University.

Who is sponsoring NCT06530264?

NCT06530264 is sponsored by Minia University.

What drugs are being tested in NCT06530264?

Interventions in NCT06530264: DCR.

What condition does NCT06530264 study?

NCT06530264 studies Acquired Nasolacrimal Duct Obstruction.

Is NCT06530264 still recruiting?

NCT06530264 is currently recruiting now. Last updated 31 July 2024.

Last reviewed 2024-07-31 · How we verify

NCT06530264

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Different Methods of Posterior Flap Management in External Dacryocystorhinostomy

Recruiting now NA Last updated 31 July 2024

What this trial tests

NA trial testing DCR in Acquired Nasolacrimal Duct Obstruction in 100 participants. Currently enrolling.

Timeline

15 October 2022

Primary endpoint
10 October 2024

15 October 2024

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	15 October 2022
Primary completion	10 October 2024
Estimated completion	15 October 2024
Sites	1 location across Egypt

Drugs / interventions tested

Conditions studied

Acquired Nasolacrimal Duct Obstruction — all drugs for Acquired Nasolacrimal Duct Obstruction →

Sponsor

Minia University

Who can join

Adults 18 to 75, any sex, with Acquired Nasolacrimal Duct Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of DCR is to form a new, mucosa-lined pathway between the lacrimal sac and the nasal cavity where tears can bypass a lacrimal obstruction and drain directly in the nose. The original external approach was described in 19046. In 1920s, mucosal flap anastomosis was added to the procedure as a modification7, and since then, many new modifications have been made to improve the original procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06530264 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 31 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06530264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing